Therefore, we performed cerebral gene expression analyses to identify early changes in AD pathogenesis and mechanisms underlying the differences in survival rate and behavioral test results among free insulin, AAC2, and their nanofiber AAC2–INS combination. This evidence concerns the gene INS and Alzheimer disease.